470 related articles for article (PubMed ID: 22831748)
1. Clinical and molecular characterization of neonatal diabetes and monogenic syndromic diabetes in Asian Indian children.
Jahnavi S; Poovazhagi V; Mohan V; Bodhini D; Raghupathy P; Amutha A; Suresh Kumar P; Adhikari P; Shriraam M; Kaur T; Das AK; Molnes J; Njolstad PR; Unnikrishnan R; Radha V
Clin Genet; 2013 May; 83(5):439-45. PubMed ID: 22831748
[TBL] [Abstract][Full Text] [Related]
2. Functional characterization of activating mutations in the sulfonylurea receptor 1 (ABCC8) causing neonatal diabetes mellitus in Asian Indian children.
Balamurugan K; Kavitha B; Yang Z; Mohan V; Radha V; Shyng SL
Pediatr Diabetes; 2019 Jun; 20(4):397-407. PubMed ID: 30861254
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of permanent neonatal diabetes in Slovakia and successful replacement of insulin with sulfonylurea therapy in KCNJ11 and ABCC8 mutation carriers.
Stanik J; Gasperikova D; Paskova M; Barak L; Javorkova J; Jancova E; Ciljakova M; Hlava P; Michalek J; Flanagan SE; Pearson E; Hattersley AT; Ellard S; Klimes I
J Clin Endocrinol Metab; 2007 Apr; 92(4):1276-82. PubMed ID: 17213273
[TBL] [Abstract][Full Text] [Related]
4. Neonatal diabetes: an expanding list of genes allows for improved diagnosis and treatment.
Greeley SA; Naylor RN; Philipson LH; Bell GI
Curr Diab Rep; 2011 Dec; 11(6):519-32. PubMed ID: 21993633
[TBL] [Abstract][Full Text] [Related]
5. Activating mutations in the ABCC8 gene in neonatal diabetes mellitus.
Babenko AP; Polak M; Cavé H; Busiah K; Czernichow P; Scharfmann R; Bryan J; Aguilar-Bryan L; Vaxillaire M; Froguel P
N Engl J Med; 2006 Aug; 355(5):456-66. PubMed ID: 16885549
[TBL] [Abstract][Full Text] [Related]
6. Successful sulfonylurea treatment of a neonate with neonatal diabetes mellitus due to a novel missense mutation, p.P1199L, in the ABCC8 gene.
Oztekin O; Durmaz E; Kalay S; Flanagan SE; Ellard S; Bircan I
J Perinatol; 2012 Aug; 32(8):645-7. PubMed ID: 22842804
[TBL] [Abstract][Full Text] [Related]
7. Molecular Genetics, Clinical Characteristics, and Treatment Outcomes of K
Ngoc CTB; Dien TM; De Franco E; Ellard S; Houghton JAL; Lan NN; Thao BP; Khanh NN; Flanagan SE; Craig ME; Dung VC
Front Endocrinol (Lausanne); 2021; 12():727083. PubMed ID: 34566892
[TBL] [Abstract][Full Text] [Related]
8. Clinical and Molecular Characterization of Children with Neonatal Diabetes Mellitus at a Tertiary Care Center in Northern India.
Jain V; Satapathy A; Yadav J; Sharma R; Radha V; Mohan V; De Franco E; Ellard S
Indian Pediatr; 2017 Jun; 54(6):467-471. PubMed ID: 28667717
[TBL] [Abstract][Full Text] [Related]
9. Permanent neonatal diabetes due to activating mutations in ABCC8 and KCNJ11.
Edghill EL; Flanagan SE; Ellard S
Rev Endocr Metab Disord; 2010 Sep; 11(3):193-8. PubMed ID: 20922570
[TBL] [Abstract][Full Text] [Related]
10. Permanent neonatal diabetes caused by a novel mutation.
Jain V; Flanagan SE; Ellard S
Indian Pediatr; 2012 Jun; 49(6):486-8. PubMed ID: 22796691
[TBL] [Abstract][Full Text] [Related]
11. Mutations in ATP-sensitive K+ channel genes cause transient neonatal diabetes and permanent diabetes in childhood or adulthood.
Flanagan SE; Patch AM; Mackay DJ; Edghill EL; Gloyn AL; Robinson D; Shield JP; Temple K; Ellard S; Hattersley AT
Diabetes; 2007 Jul; 56(7):1930-7. PubMed ID: 17446535
[TBL] [Abstract][Full Text] [Related]
12. Mutations in the ABCC8 (SUR1 subunit of the K(ATP) channel) gene are associated with a variable clinical phenotype.
Klupa T; Kowalska I; Wyka K; Skupien J; Patch AM; Flanagan SE; Noczynska A; Arciszewska M; Ellard S; Hattersley AT; Sieradzki J; Mlynarski W; Malecki MT
Clin Endocrinol (Oxf); 2009 Sep; 71(3):358-62. PubMed ID: 19021632
[TBL] [Abstract][Full Text] [Related]
13. Neonatal diabetes due to potassium channel mutation: Response to sulfonylurea according to the genotype.
Garcin L; Mericq V; Fauret-Amsellem AL; Cave H; Polak M; Beltrand J
Pediatr Diabetes; 2020 Sep; 21(6):932-941. PubMed ID: 32418263
[TBL] [Abstract][Full Text] [Related]
14. Clinical and genetic features of Argentinian children with diabetes-onset before 12months of age: Successful transfer from insulin to oral sulfonylurea.
Taberner P; Flanagan SE; Mackay DJ; Ellard S; Taverna MJ; Ferraro M
Diabetes Res Clin Pract; 2016 Jul; 117():104-10. PubMed ID: 27329029
[TBL] [Abstract][Full Text] [Related]
15. A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes.
Proks P; Arnold AL; Bruining J; Girard C; Flanagan SE; Larkin B; Colclough K; Hattersley AT; Ashcroft FM; Ellard S
Hum Mol Genet; 2006 Jun; 15(11):1793-800. PubMed ID: 16613899
[TBL] [Abstract][Full Text] [Related]
16. Sulfonylurea in the treatment of neonatal diabetes mellitus children with heterogeneous genetic backgrounds.
Zhang M; Chen X; Shen S; Li T; Chen L; Hu M; Cao L; Cheng R; Zhao Z; Luo F
J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):877-84. PubMed ID: 25781672
[TBL] [Abstract][Full Text] [Related]
17. Clinical presentation and long-term outcome of patients with KCNJ11/ABCC8 variants: Neonatal diabetes or MODY in the DPV registry from Germany and Austria.
Warncke K; Eckert A; Kapellen T; Kummer S; Raile K; Dunstheimer D; Grulich-Henn J; Woelfle J; Wenzel S; Hofer SE; Dost A; Holl RW
Pediatr Diabetes; 2022 Nov; 23(7):999-1008. PubMed ID: 35822653
[TBL] [Abstract][Full Text] [Related]
18. Molecular and clinical features of K
Hashimoto Y; Dateki S; Hirose M; Satomura K; Sawada H; Mizuno H; Sugihara S; Maruyama K; Urakami T; Sugawara H; Shirai K; Yorifuji T
Pediatr Diabetes; 2017 Nov; 18(7):532-539. PubMed ID: 27681997
[TBL] [Abstract][Full Text] [Related]
19. Three cases of permanent neonatal diabetes mellitus: genotypes and management outcome.
Ooi HL; Wu LL
Singapore Med J; 2012 Jul; 53(7):e142-4. PubMed ID: 22815030
[TBL] [Abstract][Full Text] [Related]
20. Heterozygous ABCC8 mutations are a cause of MODY.
Bowman P; Flanagan SE; Edghill EL; Damhuis A; Shepherd MH; Paisey R; Hattersley AT; Ellard S
Diabetologia; 2012 Jan; 55(1):123-7. PubMed ID: 21989597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
